首页> 外文OA文献 >Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma

【2h】

Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma

机译：Zeste同源物2（EZH2）的增强剂调节肿瘤血管生成并预测肝内胆管癌的复发和预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shigeki Nakagawa; Hirohisa Okabe; Mayuko Ouchi; Ryuma Tokunaga; Naoki Umezaki; Takaaki Higashi; Takatoshi Kaida; Kota Arima; Yuki Kitano; Hideyuki Kuroki; Kosuke Mima; Hidetoshi Nitta; Katsunori Imai; Daisuke Hashimoto; Yo-ichi Yamashita; Akira Chikamoto; Hideo Baba;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma [J] . Shigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, HPB: the official journal of the International Hepato Pancreato Biliary Association . 2018,第10期

机译：Zeste同源物的增强剂2（EZH2）调节肿瘤血管生成并预测肝内胆管癌的复发和预后
2. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters [J] . Melling Nathaniel, Thomsen Erik, Tsourlakis Maria Christina, Carcinogenesis . 2015,第11期

机译：Zeste同源物2（EZH2）增强子的过表达表征了前列腺癌的侵袭性子集，并独立于术前和术后评估的临床病理学参数预测了患者的预后
3. Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors [J] . Yap Timothy A., Winter Jane N., Giulino-Roth Lisa, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第24期

机译：在晚期血液管病和实体瘤患者中，I阶段研究Zeste同源物2（EZH2）抑制剂GSK2816126的新型增强剂
4. Up-Regulation of Enhancer of Zeste Homolog 2 Is Associated Positively With Cyclin Dl Overexpression and Poor Clinical Outcome in Head and Neck Squamous Cell Carcinoma [C] . Wei Cao, Zhien Feng, Zhibin Cui, Academic Committee conference of Shanghai key lab of stomatology . 2011

机译：Zeste同源2的增强子的上调与Cyclin Dl过度表达和头颈部鳞状细胞癌的不良临床结果呈正相关。
5. Role of Cell Cycle Regulators Enhancer of Zeste Homolog 2 and Cell Division Cycle 25A in Tumorigenesis of the Aerodigestive Tract [D] . Younis, Rania H. 2011

机译：Zeste同源2和细胞分裂周期25A的细胞周期调节剂增强剂在消化道肿瘤发生中的作用。
6. Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E [O] . Nicole K. H. Yiew, Charlotte Greenway, Abdalrahman Zarzour, 2019

机译：zeste同源物2（EZH2）的增强剂调节脂肪细胞脂质代谢独立于脂肪形成的分化：载脂蛋白E的作用
7. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters [O] . Nathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, 2015

机译：Zeste同源物2（EZH2）增强子的过度表达表征前列腺癌的激进子集，并从预先和术后评估的临床病理参数中独立地预测患者预后

Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅